Thanks @jrstumph for your valuable time in moderating this session. We will meet again next month with another interesting article. #hemepathjc
Hemepath Journal Club
@HemepathJC
#OnlineJournalClub for #Hematopoietic enthusiasts, others click at your own risk, you may fall in love with #Hematopathology (Org. by @AadilAhmedMD/@Naren_ccf)
485 Following 1.9K Followers 797 Posts
Latest posts 5
Let’s welcome @jrstumph who will be moderating today’s #hemepathJC session. We will be discussing on following article: meridian.allenpress.com/aplm/article/1…
aplm.kglmeridian.com CD30+ Lymphoproliferative Disorders as Potential Candidates for CD30-Targeted Therapies Context.— In the early 1980s, a monoclonal antibody termed Ki-1 was developed against a cell line derived from a patient with Hodgkin lymphoma. This antibody detected a limited number of benign... T minus 1 day. Be prepared.
We are excited to announce that the next hemepathJC session will be on 25th August 8.30-9.30 PM EST. @jrstumph will be moderating the session. We will present the following article: meridian.allenpress.com/aplm/article/1…View quoted post on X
We are excited to announce that the next hemepathJC session will be on 25th August 8.30-9.30 PM EST. @jrstumph will be moderating the session. We will present the following article: meridian.allenpress.com/aplm/article/1…